The MRGPRX2 paradigm shift: Redefining mast cell activation pathways in chronic urticaria
{{output}}
Chronic urticaria (CU) is a skin disease characterized by recurrent episodes of vascular dilation and increased permeability of the cutaneous and mucosal microvasculature. Although antihistamines and omalizumab remain first-line and second-line therapies, resp... ...